Venezuela Medical Device Registration 2026: Five-Year Validity and Renewal Planning

1. Key takeaways

Industry sources consistently cite the validity of a Venezuelan sanitary registration certificate as 5 years, and that figure should be read as a practical estimate rather than as a number traceable to a single official citation. What matters for planning is not the number itself but the shift in what the dossier has to prove. An initial registration demonstrates that a product should be permitted to enter the market. A renewal demonstrates that the product has remained compliant while it was on the market. The evidence base is therefore different in kind, not merely in volume: one is built from design and verification material, the other from the record of what actually happened after launch.

The conclusion is this: renewal work does not start a few months before expiry, it starts on the day the certificate is issued. The core materials a renewal needs, namely post-market safety data, adverse event records and the change history, can only be generated while the certificate is held. They cannot be compiled retrospectively, because retrospective compilation produces documents whose dates do not match the period they claim to describe. A reviewer who compares record dates against the certificate term sees the gap at once.

Two operational consequences follow. First, the granting date of the certificate fixes the start of an evidence clock, not just the start of a validity period. Second, renewal has to be run as a project with a named owner, a budget line and a calendar, because it is a full administrative procedure and not a notification. Manufacturers that treat renewal as paperwork tend to discover the difference at the point where no recovery schedule is left.

2. Legal basis

Position statement: the 5-year validity period is a practical estimate widely cited across industry sources, and this verification did not obtain a Venezuelan official instrument that can be cited directly in support of it. The recommended lead time for starting a renewal is likewise a practical estimate.

The instruments that govern renewal are administrative in character. The medicines law establishes the registration obligation and the publication requirement; the 2025 circular moves the procedure onto the COMEX platform; Decreto N° 5.165 assigns handling authority for legal regime 12 to the foreign trade commission; and Circular DGSACS-008/2026 makes a valid sanitary registration a condition of import. None of them publishes a renewal checklist in the form a manufacturer would expect, which is exactly why operational practice has to be assembled from the procedure itself and confirmed at the receiving window before filing.

3. Expert insights

1. The renewal dossier and the initial dossier can be compared side by side.

The table is the most useful planning instrument available, because it separates material that can be reused from material that must be produced. Most of the administrative and quality-system layer migrates from the initial dossier with nothing more than a validity check. The safety layer does not migrate at all: it has to be built up month by month across the term, and its quality depends on whether the processes that generate it were in place from the beginning.

2. Renewal timing must account for the practical review cycle. Where the registration cycle can reach 18 to 36 months (article 12 of this series), and renewal is equally a full procedure, starting renewal 12 months before expiry is a necessary conservative arrangement. Starting only after expiry produces a gap in the certificate, and during that gap lawful import and sale are not possible. A gap of even a few months tends to cost more than the entire renewal preparation, because stock already in the channel loses its legal basis and distributors cannot invoice against an expired registration.

3. Renewal and change control have to be reconciled before filing. If undeclared changes were implemented during the term, renewal exposes two problems at once: a change-control violation and an inconsistency in the renewal dossier. The correct sequence is to complete change notifications first and then start the renewal, so that the two issues do not become entangled. Handled in that order, the change approval becomes part of the renewal narrative instead of an exception discovered during review.

4. The time-decay problem in stability data surfaces at renewal. Real-time data that supported the shelf life at first submission no longer reaches the current point once 5 years have passed, so ongoing data is needed to bridge the interval. This is the reason article 29 of this series recommends launching ongoing stability studies at the time of initial registration rather than at renewal. A study started at renewal cannot produce the retrospective coverage a reviewer is looking for.

4. Practical recommendations

1. Certificate holders: open a renewal file on the day the certificate is issued and begin archiving post-market data, adverse events, complaints and change records from that date.
2. Regulatory affairs leads: set the renewal trigger at 12 months before expiry and reserve a buffer sized against the upper end of the practical review cycle.
3. Regulatory affairs leads: close out all pending change notifications before the renewal is filed, so that the two procedures are not reviewed in parallel.
4. Quality and technical teams: keep stability studies on an ongoing basis so that data covering the current point exists at the moment of filing.
5. License holders and importers: track the renewal application separately once it is filed and do not assume it shares a status-tracking mechanism with the initial registration.

5. Verification checklist

• □ A renewal file was opened on the day the certificate was issued and data archiving has started
• □ The renewal trigger is set at 12 months before expiry
• □ Pending changes were notified before the renewal was started
• □ Stability data covers the current point in time
• □ It has been confirmed that the renewal procedure is handled on the COMEX platform

Regulatory information verified as of October 29, 2026

All conclusions published here defer to the current regulatory texts as issued by the competent authority, verified item by item before delivery.

— GRZAN Regulatory Team

GRZAN supports medical device and IVD manufacturers, importers and authorized representatives with registration and post-market compliance in Venezuela: dossier preparation and filing through the SACS and COMEX channels, license-holder coordination, technovigilance and adverse event workflows, recall and field corrective action planning, inspection readiness, and continuous monitoring of circulares and decrees. For tailored support on your Venezuela portfolio, contact the GRZAN regulatory team at info@grzanglobal.com.